The Modified Atkins Diet for Epilepsy: Two Decades of an "Alternative" Ketogenic Diet Therapy.
Level 5 - mechanism / opinion, no new human data
Narrative review summarizing historical development and existing literature without systematic search methodology
PubMed 37591065 · doi:10.1016/j.pediatrneurol.2023.07.014
What was done
This narrative review summarizes 20 years of research on the Modified Atkins Diet (MAD) for epilepsy, spanning from its initial 2003 pilot case series of six patients through subsequent clinical trials. The authors examine its history, clinical trial evidence including randomized controlled trials, implementation, adverse effects, and investigations in other neurological disorders.
What was found
The abstract reports no numerical outcomes, effect sizes, or quantitative safety endpoints. It reports qualitatively that dozens of studies encompassing hundreds of patients support MAD as an effective dietary therapy for epilepsy, particularly in adolescents and adults, with adverse effects that may be less common than with the classic ketogenic diet.
Why it matters
The Modified Atkins Diet offers a less restrictive, outpatient-initiated alternative to the classic ketogenic diet, expanding dietary therapy options for adolescents and adults with epilepsy.
Limits
The abstract provides no quantitative data, effect estimates, or statistical comparisons. As a narrative review rather than a systematic review or meta-analysis, it does not describe study search methods, inclusion criteria, or formal risk of bias assessments.
Cited by
- supports The modified Atkins diet consists of approximately 65% to 70% fat, 20% to 30% protein, and no more than 5% to 10% carbohydrates.